INTERNATIONAL PATENT: ALKEUS PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT FOR ASYMPTOMATIC STARGARDT DISEASE PATIENTS WITH GILDEURETINOL ACETATE"

GENEVA, July 14 -- ALKEUS PHARMACEUTICALS, INC. (44 Brattle St, Fl 2Cambridge, Massachusetts 02138) filed a patent application (PCT/US2024/010064) for "TREATMENT FOR ASYMPTOMATIC STARGARDT DISEASE PATIENTS WITH GILDEURETINOL ACETATE" on Jan 02, 2024. With publication no. WO/2025/147228, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAAD, Leonide C. (44 Brattle St, Fl 2Cambridge, Massachusetts 02138)

Abstract: Disclosed is a method of delaying the onset of Stargardt disease symptoms in an asymptomatic Stargardt diseas...